Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALB | P02768 | 8/20 | 0.43 |
| ▸ | CAPN1 | P07384 | 1/20 | 0.41 |
| ▸ | GLP1R | P43220 | 8/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | CTSS | P25774 | 1/20 | 0.38 |
| ▸ | CTSK | P43235 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29796125 | 0.90 | CAPN1 (0.46) | ALBCAPN1ALDH1A1TSHRMEN1 | |
| SCHEMBL15498945 | 0.89 | CAPN1 (0.47) | ALBCAPN1GLP1RALDH1A1TSHR | |
| SCHEMBL21602728 | 0.87 | CAPN1 (0.46) | ALBCAPN1GLP1RALDH1A1TSHR | |
| SCHEMBL21713193 | 0.86 | CAPN1 (0.46) | ALBCAPN1GLP1RALDH1A1TSHR | |
| SCHEMBL31045346 | 0.86 | CAPN1 (0.46) | ALBCAPN1GLP1RALDH1A1TSHR | |
| SCHEMBL24630340 | 0.86 | GLP1R (0.49) | ALBGLP1R | |
| SCHEMBL29072106 | 0.86 | GLP1R (0.49) | ALBGLP1R | |
| SCHEMBL21713192 | 0.86 | CAPN1 (0.46) | ALBCAPN1GLP1RALDH1A1TSHR | |
| SCHEMBL27150954 | 0.86 | CAPN1 (0.46) | ALBCAPN1GLP1RALDH1A1TSHR | |
| SCHEMBL27145930 | 0.86 | CAPN1 (0.46) | ALBCAPN1GLP1RALDH1A1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4608451-A1 | CD70 ANTIBODY DRUG CONJUGATES AND METHODS OF USING THE SAME | Genmab A/S (DK) | 2025-09-03 | — | — | EP | disclosed |
| WO-2024092067-A1 | CD70 ANTIBODY DRUG CONJUGATES AND METHODS OF USING THE SAME | PROFOUNDBIO US CO. (US) | 2024-05-02 | — | — | WO | disclosed |